1. INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. RESEARCH METHODOLOGY 1.2.1 SECONDARY RESEARCH 1.2.2 DATA ANALYSIS FRAMEWORK 1.2.3 MARKET SIZE ESTIMATION 1.2.4 FORECASTING 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION 2. MARKET SNAPSHOT, 2019-2030 MILLION USD 2.1. MARKET SNAPSHOT 3. PORTER’S FIVE FORCE MODEL ANALYSIS 4. MARKET DYNAMICS 4.1. GROWTH DRIVERS 4.1.1 DRIVER 1 4.1.2 DRIVER 2 4.1.3 DRIVER 3 4.1.4 DRIVER 4 4.2. CHALLENGES 4.2.1 CHALLENGE 1 4.2.2 CHALLENGE 2 4.3. OPPORTUNITIES 4.3.1 OPPORTUNITY 1 4.3.2 OPPORTUNITY 2 5. GLOBAL DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE 5.1. OVERVIEW 5.2. FRESH DONOR EGG IVF CYCLES 5.2.1 FRESH DONOR EGG IVF CYCLES MARKET, BY REGION 5.2.1.1 North America Fresh Donor Egg IVF Cycles Market, By Country 5.2.1.2 Europe Fresh Donor Egg IVF Cycles Market, By Country 5.2.1.3 Asia-Pacific Fresh Donor Egg IVF Cycles Market, By Country 5.2.1.4 Rest of World Fresh Donor Egg IVF Cycles Market, By Country 5.3. FROZEN DONOR EGG IVF CYCLES 5.3.1 FROZEN DONOR EGG IVF CYCLES MARKET, BY REGION 5.3.1.1 North America Frozen Donor Egg IVF Cycles Market, By Country 5.3.1.2 Europe Frozen Donor Egg IVF Cycles Market, By Country 5.3.1.3 Asia-Pacific Frozen Donor Egg IVF Cycles Market, By Country 5.3.1.4 Rest of World Frozen Donor Egg IVF Cycles Market, By Country 6. GLOBAL DONOR EGG IVF SERVICES MARKET, BY END USER 6.1. OVERVIEW 6.2. FERTILITY CLINICS 6.2.1 FERTILITY CLINICS MARKET, BY REGION 6.2.1.1 North America Fertility Clinics Market, By Country 6.2.1.2 Europe Fertility Clinics Market, By Country 6.2.1.3 Asia-Pacific Fertility Clinics Market, By Country 6.2.1.4 Rest of World Fertility Clinics Market, By Country 6.3. HOSPITALS 6.3.1 HOSPITALS MARKET, BY REGION 6.3.1.1 North America Hospitals Market, By Country 6.3.1.2 Europe Hospitals Market, By Country 6.3.1.3 Asia-Pacific Hospitals Market, By Country 6.3.1.4 Rest of World Hospitals Market, By Country 6.4. SURGICAL CENTERS 6.4.1 SURGICAL CENTERS MARKET, BY REGION 6.4.1.1 North America Surgical Centers Market, By Country 6.4.1.2 Europe Surgical Centers Market, By Country 6.4.1.3 Asia-Pacific Surgical Centers Market, By Country 6.4.1.4 Rest of World Surgical Centers Market, By Country 6.5. CLINICAL RESEARCH INSTITUTES 6.5.1 CLINICAL RESEARCH INSTITUTES MARKET, BY REGION 6.5.1.1 North America Clinical Research Institutes Market, By Country 6.5.1.2 Europe Clinical Research Institutes Market, By Country 6.5.1.3 Asia-Pacific Clinical Research Institutes Market, By Country 6.5.1.4 Rest of World Clinical Research Institutes Market, By Country 7. GLOBAL DONOR EGG IVF SERVICES MARKET, BY REGION 7.1. OVERVIEW 7.2. NORTH AMERICA 7.2.1 NORTH AMERICA DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE 7.2.2 NORTH AMERICA DONOR EGG IVF SERVICES MARKET, BY END USER 7.2.3 NORTH AMERICA DONOR EGG IVF SERVICES, MARKET BY COUNTRY 7.2.3.1 U.S. 7.2.3.1.1 U.S. Donor Egg IVF Services Market, By Cycle Type 7.2.3.1.2 U.S. Donor Egg IVF Services Market, By End User 7.2.3.2 Canada 7.2.3.2.1 Canada Donor Egg IVF Services Market, By Cycle Type 7.2.3.2.2 Canada Donor Egg IVF Services Market, By End User 7.3. EUROPE 7.3.1 EUROPE DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE 7.3.2 EUROPE DONOR EGG IVF SERVICES MARKET, BY END USER 7.3.3 EUROPE DONOR EGG IVF SERVICES, MARKET BY COUNTRY 7.3.3.1 Ireland 7.3.3.1.1 Ireland Donor Egg IVF Services Market, By Cycle Type 7.3.3.1.2 Ireland Donor Egg IVF Services Market, By End User 7.3.3.2 Germany 7.3.3.2.1 Germany Donor Egg IVF Services Market, By Cycle Type 7.3.3.2.2 Germany Donor Egg IVF Services Market, By End User 7.3.3.3 U.K. 7.3.3.3.1 U.K. Donor Egg IVF Services Market, By Cycle Type 7.3.3.3.2 U.K. Donor Egg IVF Services Market, By End User 7.3.3.4 France 7.3.3.4.1 France Donor Egg IVF Services Market, By Cycle Type 7.3.3.4.2 France Donor Egg IVF Services Market, By End User 7.3.3.5 Rest of Europe 7.3.3.5.1 Rest of Europe Donor Egg IVF Services Market, By Cycle Type 7.3.3.5.2 Rest of Europe Donor Egg IVF Services Market, By End User 7.4. ASIA-PACIFIC 7.4.1 ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE 7.4.2 ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET, BY END USER 7.4.3 ASIA-PACIFIC DONOR EGG IVF SERVICES, MARKET BY COUNTRY 7.4.3.1 Australia 7.4.3.1.1 Australia Donor Egg IVF Services Market, By Cycle Type 7.4.3.1.2 Australia Donor Egg IVF Services Market, By End User 7.4.3.2 New Zealand 7.4.3.2.1 New Zealand Donor Egg IVF Services Market, By Cycle Type 7.4.3.2.2 New Zealand Donor Egg IVF Services Market, By End User 7.4.3.3 Malaysia 7.4.3.3.1 Malaysia Donor Egg IVF Services Market, By Cycle Type 7.4.3.3.2 Malaysia Donor Egg IVF Services Market, By End User 7.4.3.4 Thailand 7.4.3.4.1 Thailand Donor Egg IVF Services Market, By Cycle Type 7.4.3.4.2 Thailand Donor Egg IVF Services Market, By End User 7.4.3.5 Rest of Asia-Pacific 7.4.3.5.1 Rest of Asia-Pacific Donor Egg IVF Services Market, By Cycle Type 7.4.3.5.2 Rest of Asia-Pacific Donor Egg IVF Services Market, By End User 7.5. REST OF WORLD 7.5.1 REST OF WORLD DONOR EGG IVF SERVICES MARKET, BY CYCLE TYPE 7.5.2 REST OF WORLD DONOR EGG IVF SERVICES MARKET, BY END USER 7.5.3 REST OF WORLD DONOR EGG IVF SERVICES, MARKET BY COUNTRY 7.5.3.1 Latin America 7.5.3.1.1 Latin America Donor Egg IVF Services Market, By Cycle Type 7.5.3.1.2 Latin America Donor Egg IVF Services Market, By End User 7.5.3.2 Middle East 7.5.3.2.1 Middle East Donor Egg IVF Services Market, By Cycle Type 7.5.3.2.2 Middle East Donor Egg IVF Services Market, By End User 7.5.3.3 Africa 7.5.3.3.1 Africa Donor Egg IVF Services Market, By Cycle Type 7.5.3.3.2 Africa Donor Egg IVF Services Market, By End User 8. COMPANY PROFILES 8.1. VIRTUS HEALTH 8.1.1 COMPANY OVERVIEW 8.1.2 COMPANY SNAPSHOT 8.1.3 OPERATING BUSINESS SEGMENTS 8.1.4 PRODUCT PORTFOLIO 8.1.5 BUSINESS PERFORMANCE 8.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.2. MONASH IVF WESLEY HOSPITAL AUCHENFLOWER 8.2.1 COMPANY OVERVIEW 8.2.2 COMPANY SNAPSHOT 8.2.3 OPERATING BUSINESS SEGMENTS 8.2.4 PRODUCT PORTFOLIO 8.2.5 BUSINESS PERFORMANCE 8.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.3. FERTILITY FIRST 8.3.1 COMPANY OVERVIEW 8.3.2 COMPANY SNAPSHOT 8.3.3 OPERATING BUSINESS SEGMENTS 8.3.4 PRODUCT PORTFOLIO 8.3.5 BUSINESS PERFORMANCE 8.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.4. FLINDERS REPRODUCTIVE MEDICINE PTY LTD 8.4.1 COMPANY OVERVIEW 8.4.2 COMPANY SNAPSHOT 8.4.3 OPERATING BUSINESS SEGMENTS 8.4.4 PRODUCT PORTFOLIO 8.4.5 BUSINESS PERFORMANCE 8.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.5. FERTILITY ASSOCIATES 8.5.1 COMPANY OVERVIEW 8.5.2 COMPANY SNAPSHOT 8.5.3 OPERATING BUSINESS SEGMENTS 8.5.4 PRODUCT PORTFOLIO 8.5.5 BUSINESS PERFORMANCE 8.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.6. GENEA OXFORD FERTILITY LIMITED 8.6.1 COMPANY OVERVIEW 8.6.2 COMPANY SNAPSHOT 8.6.3 OPERATING BUSINESS SEGMENTS 8.6.4 PRODUCT PORTFOLIO 8.6.5 BUSINESS PERFORMANCE 8.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.7. REPROMED 8.7.1 COMPANY OVERVIEW 8.7.2 COMPANY SNAPSHOT 8.7.3 OPERATING BUSINESS SEGMENTS 8.7.4 PRODUCT PORTFOLIO 8.7.5 BUSINESS PERFORMANCE 8.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.8. TRIO FERTILITY 8.8.1 COMPANY OVERVIEW 8.8.2 COMPANY SNAPSHOT 8.8.3 OPERATING BUSINESS SEGMENTS 8.8.4 PRODUCT PORTFOLIO 8.8.5 BUSINESS PERFORMANCE 8.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.9. THE MONTREAL FERTILITY CENTER 8.9.1 COMPANY OVERVIEW 8.9.2 COMPANY SNAPSHOT 8.9.3 OPERATING BUSINESS SEGMENTS 8.9.4 PRODUCT PORTFOLIO 8.9.5 BUSINESS PERFORMANCE 8.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.10. PROCREA FERTILITY 8.10.1 COMPANY OVERVIEW 8.10.2 COMPANY SNAPSHOT 8.10.3 OPERATING BUSINESS SEGMENTS 8.10.4 PRODUCT PORTFOLIO 8.10.5 BUSINESS PERFORMANCE 8.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.11. IVF CANADA 8.11.1 COMPANY OVERVIEW 8.11.2 COMPANY SNAPSHOT 8.11.3 OPERATING BUSINESS SEGMENTS 8.11.4 PRODUCT PORTFOLIO 8.11.5 BUSINESS PERFORMANCE 8.11.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.12. SIMS IVF 8.12.1 COMPANY OVERVIEW 8.12.2 COMPANY SNAPSHOT 8.12.3 OPERATING BUSINESS SEGMENTS 8.12.4 PRODUCT PORTFOLIO 8.12.5 BUSINESS PERFORMANCE 8.12.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.13. MERRION FERTILITY CLINIC 8.13.1 COMPANY OVERVIEW 8.13.2 COMPANY SNAPSHOT 8.13.3 OPERATING BUSINESS SEGMENTS 8.13.4 PRODUCT PORTFOLIO 8.13.5 BUSINESS PERFORMANCE 8.13.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.14. BEACON CARE FERTILITY 8.14.1 COMPANY OVERVIEW 8.14.2 COMPANY SNAPSHOT 8.14.3 OPERATING BUSINESS SEGMENTS 8.14.4 PRODUCT PORTFOLIO 8.14.5 BUSINESS PERFORMANCE 8.14.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.15. MEDFEM FERTILITY CLINIC 8.15.1 COMPANY OVERVIEW 8.15.2 COMPANY SNAPSHOT 8.15.3 OPERATING BUSINESS SEGMENTS 8.15.4 PRODUCT PORTFOLIO 8.15.5 BUSINESS PERFORMANCE 8.15.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.16. THE CAPE FERTILITY CLINIC 8.16.1 COMPANY OVERVIEW 8.16.2 COMPANY SNAPSHOT 8.16.3 OPERATING BUSINESS SEGMENTS 8.16.4 PRODUCT PORTFOLIO 8.16.5 BUSINESS PERFORMANCE 8.16.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.17. AEVITAS FERTILITY CLINIC 8.17.1 COMPANY OVERVIEW 8.17.2 COMPANY SNAPSHOT 8.17.3 OPERATING BUSINESS SEGMENTS 8.17.4 PRODUCT PORTFOLIO 8.17.5 BUSINESS PERFORMANCE 8.17.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.18. DAMAI SERVICE HOSPITAL 8.18.1 COMPANY OVERVIEW 8.18.2 COMPANY SNAPSHOT 8.18.3 OPERATING BUSINESS SEGMENTS 8.18.4 PRODUCT PORTFOLIO 8.18.5 BUSINESS PERFORMANCE 8.18.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.19. TMC FERTILITY CENTRE 8.19.1 COMPANY OVERVIEW 8.19.2 COMPANY SNAPSHOT 8.19.3 OPERATING BUSINESS SEGMENTS 8.19.4 PRODUCT PORTFOLIO 8.19.5 BUSINESS PERFORMANCE 8.19.6 KEY STRATEGIC MOVES AND DEVELOPMENT 8.20. KL FERTILITY & GYNECOLOGY CENTRE 8.20.1 COMPANY OVERVIEW 8.20.2 COMPANY SNAPSHOT 8.20.3 OPERATING BUSINESS SEGMENTS 8.20.4 PRODUCT PORTFOLIO 8.20.5 BUSINESS PERFORMANCE 8.20.6 KEY STRATEGIC MOVES AND DEVELOPMENT